READ THE LATEST MORNING NOTE
MEDEXUS CEO INTERVIEW: GROWING FAST, EBITDA POSITIVE, $27 MILLION CASH
Watch our video interview with Ken d’Entremont, CEO of Medexus Pharmaceuticals, to find out what you may be missing with this fast growing company.
CELEBRITY FACTOR DRIVING THIS RETAIL STOCK
What’s the best retail stock to buy? We’ve got it in today’s new Digest, which we’ll publish at 7 pm eastern time, accompanied by the usual email alert.
MEDEXUS PHARMACEUTICALS CEO INTERVIEW THIS WEEK
We’ll post our interview this week with Ken d’Entremont, CEO of Medexus Pharmaceuticals, a specialty pharma company with strong growth and $27 million in cash.
NINE TOP PICKS & MY DEEP DIVE ON ARITZIA ;-)
Access the new Digest to find out how an equities research team has grown its small cap portfolio by 80%+ the last three years.
TODAY’S DIGEST FEATURES TOP PICKS PORTFOLIO UP 82% SINCE INCEPTION
Nine small cap Top Picks from a research team whose portfolio is 82% higher since inception. Expect that in the new Capital Ideas Digest when it’s published today at 7 pm ET.
“HIGH-GROWTH PURE PLAY IN EARLY INNINGS OF AGGRESSIVE EXPANSION”
Trisura Group is one of the seven high conviction stocks in the new Digest. Find out why GMP is high on this pure play.